Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)

NCT01581203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

748

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus

Interventions

DRUG: Asunaprevir (ASV)
DRUG: Daclatasvir (DCV)
DRUG: Pegylated-interferon alfa 2a (PegIFN)
DRUG: Ribavirin (RBV)

Sponsor

Bristol-Myers Squibb